Shots: Immatics to get $75M up front and is also eligible to receive ~$505M as option exercise fee for each licensed product including development, regulatory & commercial milestone plus royalties […]readmore
Tags : Cell
Shots: Merck KGaA & GenScript enter into a collaboration agreement to accelerate the industrialization and commercialization of cell and gene therapy in China. Merck to provide products, services & staff […]readmore